Evidence map›Paper›PMID 38715331›Full record

ReviewCurrent pharmaceutical design2024

Endothelial-specific Enhancer as a Cis Element of

Dmitry Penkov, Irina Beloglazova, Yelena Parfyonova

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dmitry PenkovLaboratory of Angiogenesis, Institute of Experimental Cardiology Named after Academician V.N. Smirnov, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, Moscow, Russia.ORCID 0000-0002-3741-1060
Irina BeloglazovaLaboratory of Angiogenesis, Institute of Experimental Cardiology Named after Academician V.N. Smirnov, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, Moscow, Russia.ORCID 0000-0002-2345-3681
Yelena ParfyonovaLaboratory of Angiogenesis, Institute of Experimental Cardiology Named after Academician V.N. Smirnov, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, Moscow, Russia.ORCID 0000-0002-0969-5780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of human

Indexed as

Enhancer Elements, GeneticInterleukin-1betaReceptors, Urokinase Plasminogen ActivatorTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AAnimalsEndothelial CellsGene Expression RegulationHumansInterleukin-1betaPLAUR protein, humanReceptors, Urokinase Plasminogen ActivatorTumor Necrosis Factor-alphaVascular Endothelial Growth Factor Acancer.IL-1betaPLAURTNF-alphauPARVEGF

Identifiers

PMID38715331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.